Company: DRTSW
Filing Date: 2025-04-28
Form Type: 424B5
Source: 0001213900-25-035799
Chunk: 85

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-04-28
Form: 424B5
Chunk 85
---
 and sell the
securities in one or more of the following ways (or in any combination) from time to time:

| ● | through                  
 underwriters or dealers; |

| ● | directly                                                    
 to a limited number of purchasers or to a single purchaser; |

| ● | in                  
 block transactions; |

| ● | in                                                                                                
 “at the market offerings,” within the meaning of Rule 415(a)(4) of the Securities                 
 Act, to or through a market maker or into an existing trading market on an exchange or otherwise; |

| ● | through    
 agents; or |

| ● | through                                                                                             
 any other method permitted by applicable law and described in the applicable prospectus supplement. |

The prospectus supplement
will state the terms of the offering of the securities, including:

| ● | the                                                   
 name or names of any underwriters, dealers or agents; |

| ● | the                                                                              
 purchase price of such securities and the proceeds to be received by us, if any; |

| ● | any                                                                                 
 underwriting discounts or agency fees and other items constituting underwriters’ or 
 agents’ compensation;                                                               |

| ● | any                    
 public offering price; |

| ● | any                                                                   
 discounts or concessions allowed or reallowed or paid to dealers; and |

| ● | any                                                         
 securities exchanges on which the securities may be listed. |

Any public offering price
and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time.

If underwriters are used
in the sale, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or
more transactions, including:

| ● | negotiated    
 transactions; |

| ● | at                                                             
 a fixed public offering price or prices, which may be changed; |

| ● | at                                            
 market prices prevailing at the time of sale; |

| ● | at                                             
 prices related to prevailing market prices; or |

| ● | at                 
 negotiated prices. |

<div align='center'>22</div>

Unless otherwise stated
in a prospectus supplement, the obligations of the underwriters to purchase any securities will be conditioned on customary closing conditions
and the underwriters will be obligated to purchase all of such series of securities, if any are purchased.

The securities may be sold
through agents from time to time. The prospectus supplement will name any agent involved in the offer or sale of the securities and any
commissions paid to them. Generally